Heidi T Jacobe Selected Research

Localized Scleroderma (Morphea)

1/2022	Autoantigen microarrays reveal myelin basic protein autoantibodies in morphea.
3/2021	Morphea: progress to date and the road ahead.
1/2020	Changes in Disease Activity and Damage Over Time in Patients With Morphea.
10/2019	Hyaluronidase injections for treatment of symptomatic pansclerotic morphea-induced microstomia.
1/2017	Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea.
9/2016	Phototherapy for sclerosing skin conditions.
11/2011	A systematic review of morphea treatments and therapeutic algorithm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heidi T Jacobe Research Topics

Disease

7	Localized Scleroderma (Morphea) 01/2022 - 11/2011
2	Skin Diseases (Skin Disease) 01/2021 - 08/2005
1	Pain (Aches) 01/2022
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Pruritus (Itching) 01/2021
1	Calcinosis Cutis 01/2021
1	Arthritis (Polyarthritis) 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Telangiectasis (Telangiectasia) 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2021
1	Acute Generalized Exanthematous Pustulosis 11/2020
1	COVID-19 11/2020
1	Sclerosis 01/2020
1	Microstomia 10/2019
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 09/2016
1	Bronchiolitis Obliterans Syndrome 09/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2016
1	Melanoma (Melanoma, Malignant) 01/2016
1	Dermatitis 06/2010
1	Erythema 06/2010
1	Autoimmune Diseases (Autoimmune Disease) 05/2009
1	Argyria 08/2005

Drug/Important Bio-Agent (IBA)

3	Methotrexate (Mexate)FDA LinkGeneric 03/2021 - 11/2011
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
2	LigandsIBA 03/2021 - 01/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2021 - 11/2011
1	AntibodiesIBA 01/2022
1	EpitopesIBA 01/2022
1	AutoantigensIBA 01/2022
1	Myelin Basic ProteinIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	CXCR3 ReceptorsIBA 03/2021
1	CollagenIBA 03/2021
1	InterferonsIBA 03/2021
1	CalciumIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2020
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 10/2019
1	CytokinesIBA 01/2017
1	HLA-DR Antigens (HLA-DR)IBA 01/2016
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	IntegrinsIBA 01/2016
1	calcipotriene (calcipotriol)FDA LinkGeneric 11/2011
1	Tacrolimus (Prograf)FDA LinkGeneric 11/2011
1	Antinuclear AntibodiesIBA 05/2009
1	colloidal silverIBA 08/2005
1	SilverIBA 08/2005
1	SolutionsIBA 08/2005
1	SaltsIBA 08/2005

Therapy/Procedure

5	Therapeutics 03/2021 - 06/2010
2	Phototherapy (Light Therapy) 11/2011 - 06/2010
1	Dye Lasers 01/2021
1	Skin Care 01/2021
1	Injections 10/2019